SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-062301 from Immuron Ltd (IMRN) (CIK 0001660046) (IMRN)

Immuron Ltd (IMRN) (CIK 0001660046)
Date: July 18, 2024 · CIK: 0001660046 · Accession: 0001213900-24-062301

AI Filing Summary & Sentiment

File numbers found in text: 333-280667

Date
July 17, 2024
Author
IMMURON LIMITED
Form
CORRESP
Company
Immuron Ltd (IMRN) (CIK 0001660046)

Letter

IMMURON LIMITED

Level 3, 62 Lygon Street

Carlton South, Victoria, 3053, Australia

July 17, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Lauren Hamill

Re: Immuron Limited (the “Company”)

Registration Statement on Form F-3

Filed July 3, 2024

File No. 333-280667

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 PM EDT on Friday, July 19, 2024, or as soon thereafter as is practicable.

If you have any questions, please call Avital Perlman, Esq. at 212-930-9700.

Very truly yours,
IMMURON LIMITED

Show Raw Text
CORRESP
1
filename1.htm

IMMURON LIMITED

Level 3, 62 Lygon Street

Carlton South, Victoria, 3053, Australia

July 17, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Lauren Hamill

 Re: Immuron Limited (the “Company”)

Registration Statement on Form F-3

Filed July 3, 2024

File No. 333-280667

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities
Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above
be accelerated so that it will be declared effective at 4:30 PM EDT on Friday, July 19, 2024, or as soon thereafter as is practicable.

If you have any questions, please call Avital Perlman, Esq. at 212-930-9700.

    Very truly yours,

    IMMURON LIMITED

    By:
    /s/ Steven Lydeamore

    Name:
     Steven Lydeamore

    Title:
    Chief Executive Officer